Skip to main content

Table 3 Characteristics of radiation pneumonitis according to immune checkpoint inhibitor administration

From: Radiation pneumonitis in patients with non-small-cell lung cancer receiving chemoradiotherapy and an immune checkpoint inhibitor: a retrospective study

Characteristics

ICI (n = 51)

Non-ICI (n = 55)

p

Patients with RP ≥ grade 2 (n [%])

27 (52.9)

20 (36.4)

0.043

Patients with RP ≥ grade 3 (n [%])

3 (5.9)

3 (5.4)

0.924

Onset time from end of CCRT, month (median, [range])

2.3 (0.0–15.4)

3.7 (0.0–7.5)

0.782

Onset time from the start of ICI, month (median, [range])

1.4 (0.0–5.8)

Duration of steroid use, day (median, [range])

56 (16–238)

67 (6–114)

0.848

  1. RP Radiation pneumonitis, ICI Immune checkpoint inhibitor, CCRT Concurrent chemoradiotherapy
  2. Only for patients with RT pneumonitis ≥ grade 2